Analysts’ updated eps estimates for Tuesday, September 29th:
Arbor Realty Trust (NYSE:ABR) had its market perform rating reissued by analysts at Citizens Jmp.
Acurx Pharmaceuticals (NASDAQ:ACXP) had its buy rating reissued by analysts at HC Wainwright.
C3.ai (NYSE:AI) had its market perform rating reiterated by analysts at Citizens Jmp.
Aldeyra Therapeutics (NASDAQ:ALDX) had its buy rating reaffirmed by analysts at BTIG Research.
Advanced Micro Devices (NASDAQ:AMD) had its buy rating reiterated by analysts at Rosenblatt Securities. They currently have a $700.00 price target on the stock.
Affiliated Managers Group (NYSE:AMG) had its buy rating reiterated by analysts at TD Cowen. They currently have a $512.00 target price on the stock.
Amprius Technologies (NYSE:AMPX) had its buy rating reissued by analysts at HC Wainwright. They currently have a $18.00 price target on the stock.
AstraZeneca (LON:AZN) had its hold rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. They currently have a £117 target price on the stock.
Bloomin’ Brands (NASDAQ:BLMN) was upgraded by analysts at JPMorgan Chase & Co. from an underweight rating to a neutral rating. The firm currently has $13.00 target price on the stock, up from their previous target price of $6.00.
Braemar (LON:BMS) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 320 price target on the stock.
Hollywood Bowl Group (LON:BOWL) had its buy rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 450 price target on the stock.
Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) had its outperform rating reissued by analysts at Wedbush. Wedbush currently has a $40.00 price target on the stock.
Duolingo (NASDAQ:DUOL) had its buy rating reissued by analysts at DA Davidson. They currently have a $175.00 target price on the stock.
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) was downgraded by analysts at Berenberg Bank from a buy rating to a hold rating.
Genius Sports (NYSE:GENI) was downgraded by analysts at Wall Street Zen from a sell rating to a strong sell rating.
GSK (LON:GSK) had its hold rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 2,000 target price on the stock.
Ichor (NASDAQ:ICHR) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Lifecore Biomedical (NASDAQ:LFCR) had its market perform rating reiterated by analysts at Barrington Research.
Life360 (NASDAQ:LIF) had its neutral rating reiterated by analysts at DA Davidson. The firm currently has a $40.00 price target on the stock.
MongoDB (NASDAQ:MDB) had its buy rating reiterated by analysts at DA Davidson. They currently have a $465.00 target price on the stock.
Merit Medical Systems (NASDAQ:MMSI) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $101.00 target price on the stock.
monday.com (NASDAQ:MNDY) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to a neutral rating. They currently have $87.00 price target on the stock, down from their previous price target of $90.00.
Modine Manufacturing (NYSE:MOD) had its buy rating reissued by analysts at DA Davidson. The firm currently has a $330.00 price target on the stock.
Netflix (NASDAQ:NFLX) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a hold rating to a buy rating. The firm currently has $95.00 target price on the stock, down from their previous target price of $100.00.
NVIDIA (NASDAQ:NVDA) had its buy rating reaffirmed by analysts at Rosenblatt Securities. The firm currently has a $390.00 price target on the stock.
Navitas Semiconductor (NASDAQ:NVTS) had its neutral rating reiterated by analysts at Rosenblatt Securities. The firm currently has a $13.00 target price on the stock.
Ocular Therapeutix (NASDAQ:OCUL) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $18.00 target price on the stock.
PepsiCo (NASDAQ:PEP) had its neutral rating reissued by analysts at JPMorgan Chase & Co.. They currently have a $138.00 price target on the stock, down from their previous price target of $170.00.
Plug Power (NASDAQ:PLUG) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $7.00 price target on the stock.
Primoris Services (NYSE:PRIM) had its neutral rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $105.00 price target on the stock.
Pershing Square (NYSE:PS) had its hold rating reaffirmed by analysts at JonesTrading.
Quantum-Si (NASDAQ:QSI) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $4.00 target price on the stock.
Regeneron Pharmaceuticals (NASDAQ:REGN) had its sector perform rating reiterated by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $737.00 target price on the stock.
Cartesian Therapeutics (NASDAQ:RNAC) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $40.00 price target on the stock.
Rentokil Initial (NYSE:RTO) was downgraded by analysts at Morgan Stanley from an overweight rating to an equal weight rating.
Rezolute (NASDAQ:RZLT) was upgraded by analysts at Craig Hallum from a hold rating to a buy rating. They currently have $7.00 target price on the stock, up from their previous target price of $4.00.
Stitch Fix (NASDAQ:SFIX) was upgraded by analysts at Mizuho from an underperform rating to a neutral rating. The firm currently has $2.50 price target on the stock, down from their previous price target of $3.00.
Smiths News (LON:SNWS) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 95 target price on the stock.
STAAR Surgical (NASDAQ:STAA) was upgraded by analysts at Stifel Nicolaus from a hold rating to a buy rating. Stifel Nicolaus currently has $31.00 price target on the stock, up from their previous price target of $28.00.
S&U (LON:SUS) had its buy rating reiterated by analysts at Berenberg Bank. The firm currently has a GBX 2,310 price target on the stock.
Ubiquiti (NYSE:UI) had its buy rating reaffirmed by analysts at BWS Financial. They currently have a $980.00 price target on the stock.
Valley National Bancorp (NASDAQ:VLY) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. They currently have a $17.00 price target on the stock.
Vulcan Energy Resources (LON:VUL) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 308 price target on the stock.
NCR Voyix (NYSE:VYX) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $14.00 price target on the stock.
Warner Bros. Discovery (NASDAQ:WBD) had its sell rating reaffirmed by analysts at Argus.
Wilmington (LON:WIL) had its buy rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 485 price target on the stock.
Warner Music Group (NASDAQ:WMG) had its buy rating reiterated by analysts at Guggenheim. They currently have a $36.00 price target on the stock.
XPENG (NYSE:XPEV) had its neutral rating reaffirmed by analysts at JPMorgan Chase & Co.. They currently have a $11.50 target price on the stock, down from their previous target price of $24.00.
Receive News & Ratings for Arbor Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arbor Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.
